Literature DB >> 3900102

Growth factor production during multistage transformation of epithelium in vitro. I. Partial purification and characterisation of the factor(s) from a fully transformed epithelial cell line.

C B Wigley, L K Trejdosiewicz, J Southgate, R Coventry, B Ozanne.   

Abstract

Transforming growth factor (TGF)-like activity is characterised from one of a series of salivary epithelial cell lines, CSG 211, chemically transformed in vitro. In this transformation system, we can demonstrate multiple stages in the acquisition of a malignant phenotype by normal diploid ductal epithelial cells from male mouse submandibular gland. The fully transformed, tumorigenic cell TGF-like activity in serum-free supernatants resembles no other well-characterised growth factor and has an apparent molecular weight (Mr) of 14 kd. There is also evidence of a higher Mr activity, which is separable by anion exchange chromatography. We show that the premalignant, nontumorigenic progenitor cells of this line do not produce demonstrable TGF-like activity and that this property is therefore acquired as CSG 211 cells become carcinoma producing.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900102     DOI: 10.1002/jcp.1041250120

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  3 in total

1.  Enhanced proliferation of cells from human tissue explants following irradiation in the presence of environmental carcinogens.

Authors:  C Mothersill; A Cusack; C B Seymour
Journal:  Radiat Environ Biophys       Date:  1989       Impact factor: 1.925

2.  Growth factor(s) produced during infection with an adenovirus variant stimulates proliferation of nonestablished epithelial cells.

Authors:  M P Quinlan; N Sullivan; T Grodzicker
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

3.  Elevated production of growth factor by human premalignant colon adenomas and a derived epithelial cell line.

Authors:  C B Wigley; C Paraskeva; R Coventry
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.